C12Q 2525/113
Incorporating modified backbone
Official title: incorporating modified backbone
C12Q2525/113 (Incorporating modified backbone) appears on 34 US grants and 51 published applications in this corpus.
Search patents in C12Q- Granted patents
- 34
- Published applications
- 51
- Assignees
- 30
- Inventors
- 111
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 1 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 2 |
| 2016 | 4 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 5 |
| 2019 | 2 | 5 |
| 2020 | 3 | 1 |
| 2021 | 4 | 9 |
| 2022 | 1 | 7 |
| 2023 | 9 | 3 |
| 2024 | 1 | 3 |
| 2025 | 1 | 3 |
| 2026 | 3 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- 3′ protected nucleotides6 Oct 2026US 12,753,201 B2Roche Sequencing Solutions, Inc.
- Methods and compositions for nucleic acid sequencing28 Jul 2026US 12,692,541 B2Illumina, Inc.
- Method for multiplex nucleic acid detection based on clustered regularly interspaced short palindromic repeat2 Jun 2026US 12,644,147 B2Shandong Shunfeng Biotechnology Co., Ltd.
- Compositions and methods for detecting or quantifying hepatitis C virus9 Dec 2025US 12,492,437 B2Gen-Probe Incorporated
- Chemically-enhanced primer compositions, methods and kits11 Jun 2024US 12,006,536 B2Life Technologies Corporation
- Kits for genotyping6 Aug 2026US 2026/0226545 A1Illumina Cambridge Limited
- Preparation and use of blocked substrates19 Jun 2025US 2025/0197918 A1Illumina, Inc.
- Chemically-enhanced primer compositions, methods and kits16 Jan 2025US 2025/0019756 A1Life Technologies Corporation
- Method of examining a nucleic acid amplification product9 Jan 2025US 2025/0011853 A1Qiagen GmbH
- Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection27 Jun 2024US 2024/0209432 A1Roche Sequencing Solutions, Inc.
Most cited
By later US patents
- Field-switch sequencing180US 7,462,452 B2Pacific Biosciences of California, Inc. · 2008
- Enhancing specificity of analyte binding87US 11,702,698 B210x Genomics, Inc. · 2023
- Field-switch sequencing14US 8,592,148 B2Pacific Biosciences of California, Inc. · 2013
- Field switch sequencing8US 9,045,798 B1Pacific Biosciences of California, Inc. · 2015
- Chemically-enhanced primer compositions, methods and kits5US 8,703,925 B2Life Technologies Corporation · 2014